We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Hikma Pharmaceuticals Plc | LSE:HIK | London | Ordinary Share | GB00B0LCW083 | ORD SHS 10P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
59.00 | 3.18% | 1,913.00 | 1,916.00 | 1,918.00 | 1,920.00 | 1,861.00 | 1,861.00 | 522,491 | 16:35:11 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 2.88B | 192M | 0.8685 | 22.08 | 4.24B |
MADISON, Wis., Feb. 8, 2018 /PRNewswire/ -- Propeller Health, the leading digital solution for respiratory medicine, has been awarded International Organization for Standardization (ISO) 13485:2016 certification for medical device quality management systems. Propeller's FDA-cleared medical devices include sensors that attach to inhalers and mobile apps powered by a robust analytics platform helping patients better manage their asthma and COPD symptoms. The platform's clinician tools are used by providers and healthcare organizations to help improve care and treatment and strengthen their relationship with patients. This ISO certification is another milestone for Propeller following the company's recently announced partnership with the largest pharmacy benefit management organization in the U.S., Express Scripts, and expansion of work with GlaxoSmithKline.
About Propeller's ISO 13485 certification:
"Having an ISO 13485 quality system means that we have validated processes which enable us to innovate at the speed required to safely bring respiratory health innovation to our patients while rapidly scaling our platform," said Taylor Mahan-Rudolph, Regulatory and Quality Assurance Lead at Propeller Health.
For more technical specs and certifications related to Propeller's platform for managing chronic respiratory disease, please visit propellerhealth.com/enterprise.
About Propeller
Propeller empowers people with asthma and COPD to live measurably better lives. In 2010, Propeller set out to modernize respiratory medicine; enable people to minimize the impact of asthma and COPD on their daily lives; and connect them to their physicians, environment, and community. Propeller's information-powered approach to respiratory management guides physicians and patients to the optimal path of therapy for each individual. With connected inhalers, digital interfaces, and personalized insights, participants receive personal guidance and expert direction anytime. Backed by 3M Ventures (NYSE: MMM), SR One, Hikma Ventures (LON: HIK), Safeguard Scientifics (NYSE: SFE), Social Capital, and other investors, Propeller received the American Telemedicine Association's 2016 President's Award for Innovation in Remote Healthcare and was recognized as one of the top "Fierce 15" medical device companies in 2015 by FierceMedicalDevices. In 2017, Fast Company named Propeller as one of the most innovative companies in health.
View original content:http://www.prnewswire.com/news-releases/propeller-health-achieves-iso-13485-medical-device-quality-certification-300595606.html
SOURCE Propeller Health
Copyright 2018 PR Newswire
1 Year Hikma Pharmaceuticals Chart |
1 Month Hikma Pharmaceuticals Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions